Effect of non surgical periodontal therapy in treatment of diabetes

Evaluation of effect of nonsurgical periodontal therapy on hemoglobin A1c and c1 reactive protein value in type 2 diabetes mellitus pateints.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190721044287N1

Enrollment

Registered

2019-12-21

Start date

2019-10-23

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: moderate chronic periodontitis. Condition 2: Type 2 diabetes mellitus. Chronic periodontitis Type 2 diabetes mellitus

Interventions

Intervention 1: In intervention group scaling and root planning are performed for patients by an ultrasonic device with slim head in a one hour session . supra gingival and sub gingival calculus is re

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with chronic periodontitis who have not received any periodontal treatment in the past 6 months Periodontal patients who have not received any antimicrobial treatment in the past 3 months Patients with at least 14 teeth in mouth and pocket depth = 5 mm in at least 4 areas and clinical attachment loss =3 mm in at least 4 areas Diabetes diagnosed by a physician for about 6 months Patients unchanged in their diabetic drug regimen for the past 3 months

Exclusion criteria

Exclusion criteria: Patients with advanced diabetic problems (macrovascular and microvascular) Chronic pulmonary disease Kidney and liver disease Malignancies Heart disease (coronary artery disease) Transplanted patients History of infection and trauma Alcoholic and Smoker Patients Pregnant people Patients with severe periodontitis

Design outcomes

Primary

Measure	Time frame
Hb A1c. Timepoint: At baseline and 3 months later. Method of measurement: Sebia apparatus for measuring Hba1c using electrophoresis capillary kit.;C1 Reactive Protein. Timepoint: At baseline and 3 month later. Method of measurement: Hitachi912 apparatus for measuring c1 reactive protein using bionik kit.;Clinical attachment loss index. Timepoint: At baseline and 3 months later. Method of measurement: Using William's periodontal probe.;Gingival index. Timepoint: At baseline and 3 month later. Method of measurement: Using Leo & Sillness gingival inflammation index.;Pocket depth index. Timepoint: At baseline and 3 month later. Method of measurement: Using William's periodontal probe.;Gingival bleeding index. Timepoint: At baseline and 3 month later. Method of measurement: Using William's periodontal probe.;Plaque index. Timepoint: At baseline and 3 month later. Method of measurement: Using disclosing agent by O'leary Index method.	—

Measure

Time frame

Hb A1c. Timepoint: At baseline and 3 months later. Method of measurement: Sebia apparatus for measuring Hba1c using electrophoresis capillary kit.;C1 Reactive Protein. Timepoint: At baseline and 3 month later. Method of measurement: Hitachi912 apparatus for measuring c1 reactive protein using bionik kit.;Clinical attachment loss index. Timepoint: At baseline and 3 months later. Method of measurement: Using William's periodontal probe.;Gingival index. Timepoint: At baseline and 3 month later. Method of measurement: Using Leo & Sillness gingival inflammation index.;Pocket depth index. Timepoint: At baseline and 3 month later. Method of measurement: Using William's periodontal probe.;Gingival bleeding index. Timepoint: At baseline and 3 month later. Method of measurement: Using William's periodontal probe.;Plaque index. Timepoint: At baseline and 3 month later. Method of measurement: Using disclosing agent by O'leary Index method.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRashed Ghorbandoust

Rasht University of Medical Sciences

rashed.ghd@gmail.com+98 13 3324 2361

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026